Form 4: Guardant Health's Chief Legal Officer Reports Stock Transactions
SEC Form 4 Filing
John G. Saia, Chief Legal Officer of Guardant Health, Inc., reports the vesting of restricted stock units and associated tax withholding.
Summary
- On March 1, 2024, John G. Saia, the Chief Legal Officer of Guardant Health, Inc., engaged in transactions involving the company's stock.
- Specifically, 263 shares were acquired through the vesting of restricted stock units at a price of $0.
- Additionally, 108 shares were withheld by the company to cover tax obligations related to the vesting, at a price of $18.97.
- Following these transactions, Saia directly owns 21,331 shares of Guardant Health common stock and 1,579 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions, with neutral sentiment.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders, as they relate to executive compensation and tax obligations.
Key Dates
| Date | Description |
|---|---|
| 09/01/2022 | Initial vesting date of 25% of the restricted stock units. |
| 03/01/2024 | Date of transaction: vesting of restricted stock units and tax withholding. |
| 03/04/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.